These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34877267)

  • 1. Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography.
    Dong Z; Lin Y; Lin F; Luo X; Lin Z; Zhang Y; Li L; Li ZP; Feng ST; Cai H; Peng Z
    J Hepatocell Carcinoma; 2021; 8():1473-1484. PubMed ID: 34877267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.
    Ma J; Bo Z; Zhao Z; Yang J; Yang Y; Li H; Yang Y; Wang J; Su Q; Wang J; Chen K; Yu Z; Wang Y; Chen G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma.
    Zhang L; Jin Z; Li C; He Z; Zhang B; Chen Q; You J; Ma X; Shen H; Wang F; Wu L; Ma C; Zhang S
    Radiol Med; 2024 Mar; 129(3):353-367. PubMed ID: 38353864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models.
    An H; Bhatia I; Cao F; Huang Z; Xie C
    BMC Cancer; 2023 Mar; 23(1):201. PubMed ID: 36869284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
    Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
    Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting One-year Recurrence of HCC based on Gadoxetic Acid-enhanced MRI by Machine Learning Models.
    Lin Y; Wang J; Chen Y; Zhou X; Tang M; Chen M; Song C; Xu D; Peng Z; Feng ST; Zhou C; Dong Z
    Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38462826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors.
    Zhao SM; Qiu LW; Zhao H; Gu WW; Yang XH; Gu ZX; Shi RF; Ni CF
    J Cancer Res Ther; 2021 Jul; 17(3):707-714. PubMed ID: 34269303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
    Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.
    Liu W; Wei R; Chen J; Li Y; Pang H; Zhang W; An C; Li C
    Eur Radiol; 2024 Aug; 34(8):5094-5107. PubMed ID: 38291256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI.
    Chen M; Kong C; Qiao E; Chen Y; Chen W; Jiang X; Fang S; Zhang D; Chen M; Chen W; Ji J
    Insights Imaging; 2023 Feb; 14(1):38. PubMed ID: 36854872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of mRECIST in Measurement and Response Assessment for Hepatocellular Carcinoma Treated by Transarterial Chemoembolization.
    Choi MH; Park GE; Oh SN; Park MY; Rha SE; Lee YJ; Jung SE; Choi JI
    Acad Radiol; 2018 Nov; 25(11):1363-1373. PubMed ID: 29555570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
    Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients.
    Sun T; Zhang W; Chen L; Ren Y; Liu Y; Zheng C
    J Cancer; 2022; 13(4):1282-1288. PubMed ID: 35281867
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma].
    Yu YX; Hu CH; Wang XM; Fan YF; Hu MJ; Shi C; Hu S; Zhu M; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1239-1245. PubMed ID: 34865392
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study.
    Zou ZM; An TZ; Li JX; Zhang ZS; Xiao YD; Liu J
    J Cancer; 2021; 12(23):7079-7087. PubMed ID: 34729109
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning.
    Peng J; Huang J; Huang G; Zhang J
    Front Oncol; 2021; 11():730282. PubMed ID: 34745952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.